Straube, A., Pfaffenrath, V., Ladwig, K. H., Meisinger, C., Hoffmann, W., Fendrich, K., et al. (2010). Prevalence of chronic migraine and medication overuse headache in Germany—The German DMKG headache study. Cephalalgia, 30(2), 207–213.
Article
CAS
PubMed
Google Scholar
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barre, J., Katsarava, Z., et al. (2012). The cost of headache disorders in Europe: The Eurolight project. European Journal of Neurology, 19(5), 703–711.
Article
CAS
PubMed
Google Scholar
Headache Classification Committee of the International Headache Society (HIS). (2018). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia, 38(1), 1–211.
Article
Google Scholar
Dichgans, J., Diener, H. C., Gerber, W. D., Verspohl, E. J., Kukiolka, H., & Kluck, M. (1984). Analgetika-induzierter Dauerkopfschmerz. Dtsch med Wschr., 109, 369–373.
Article
CAS
PubMed
Google Scholar
Horton, B. T., & Peters, G. A. (1963). Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: Report of 52 cases. Headache, 3, 214–226.
Article
Google Scholar
Kaube, H., May, A., Diener, H. C., & Pfaffenrath, V. (1994). Sumatriptan misuse in daily chronic headache. BMJ, 308, 1573.
Article
CAS
PubMed
PubMed Central
Google Scholar
Diener, H. C., & Limmroth, V. (2004). Medication-overuse headache: A worldwide problem. Lancet Neurology, 3(8), 475–483.
Article
PubMed
Google Scholar
Kristoffersen, E. S., & Lundqvist, C. (2014). Medication-overuse headache: Epidemiology, diagnosis and treatment. Therapeutic Advances in Drug Safety, 5(2), 87–99.
Article
PubMed
PubMed Central
Google Scholar
Global Burden of Disease Neurological Disorders Collaborator Group. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurology, 16(11), 877–897.
Article
Google Scholar
Wang, S. J., Fuh, J. L., Lu, S. R., & Juang, K. D. (2006). Chronic daily headache in adolescents: Prevalence, impact, and medication overuse. Neurology, 66(2), 193–197.
Article
PubMed
Google Scholar
Westergaard, M. L., Hansen, E. H., Glumer, C., Olesen, J., & Jensen, R. H. (2014). Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia, 34(6), 409–425.
Article
PubMed
Google Scholar
Porst, M., Wengler, A., Leddin, J., Neuhauser, H., Katsarava, Z., von der Lippe, E., et al. (2020). Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study. Journal of Health Monitoring., 5(S6), 2–24.
PubMed
PubMed Central
Google Scholar
Schramm, S. H., Obermann, M., Katsarava, Z., Diener, H. C., Moebus, S., & Yoon, M. S. (2013). Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. The Journal of Headache and Pain, 14, 40.
Article
PubMed
PubMed Central
Google Scholar
Katsarava, Z., Schneeweiss, S., Kurth, T., Kroener, U., Fritsche, G., Eikermann, A., et al. (2004). Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology, 62(5), 788–790.
Article
CAS
PubMed
Google Scholar
Limmroth, V., Katsarava, Z., Fritsche, G., Przywara, S., & Diener, H. C. (2002). Features of medication overuse headache following overuse of different acute headache drugs. Neurology, 59(7), 1011–1014.
Article
CAS
PubMed
Google Scholar
Créac’h, C., Radat, F., Mick, G., Guegan-Massardier, E., Giraud, P., Guy, N., et al. (2009). One or several types of triptan overuse headaches? Headache: The Journal of Head and Face Pain, 49(4), 519–528.
Article
Google Scholar
Bigal, M. E., Borucho, S., Serrano, D., & Lipton, R. B. (2009). The acute treatment of episodic and chronic migraine in the USA. Cephalalgia, 29(8), 891–897.
Article
CAS
PubMed
Google Scholar
Thorlund, K., Sun-Edelstein, C., Druyts, E., Kanters, S., Ebrahim, S., Bhambri, R., et al. (2016). Risk of medication overuse headache across classes of treatments for acute migraine. The Journal of Headache and Pain, 17(1), 107.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lipton, R. B., Diener, H. C., Robbins, M. S., Garas, S. Y., & Patel, K. (2017). Caffeine in the management of patients with headache. The Journal of Headache and Pain, 18(1), 107.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zeeberg, P., Olesen, J., & Jensen, R. (2009). Medication overuse headache and chronic migraine in a specialized headache centre: Field-testing proposed new appendix criteria. Cephalalgia, 29(2), 214–220.
Article
CAS
PubMed
Google Scholar
Lance, F., Parkes, C., & Wilkinson, M. (1988). Does analgesic abuse cause headaches de novo? Headache, 28(1), 61–62.
Article
CAS
PubMed
Google Scholar
Bahra, A., Walsh, M., Menon, S., & Goadsby, P. J. (2003). Does chronic daily headache arise de novo in association with regular use of analgesics? Headache, 43, 179–190.
Article
PubMed
Google Scholar
Sarchielli, P., Corbelli, I., Messina, P., Cupini, L. M., Bernardi, G., Bono, G., et al. (2016). Psychopathological comorbidities in medication-overuse headache: A multicentre clinical study. European Journal of Neurology, 23(1), 85–91.
Article
CAS
PubMed
Google Scholar
Ljubisavljevic, M., Ignjatovic, A., Djordjevic, V., Pesic, M. H., & Ljubisavljevic, S. (2021). Depression, anxiety, stress, and health-related quality of life among patients with medication overuse headache in a tertiary headache center: A cross-sectional study. Journal of Neuropsychiatry and Clinical Neurosciences, 33(2), 132–143.
Article
PubMed
Google Scholar
Hagen, K., Linde, M., Steiner, T. J., Stovner, L. J., & Zwart, J. A. (2012). Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag health studies. Pain, 153, 56–61.
Article
PubMed
Google Scholar
Fritsche, G., Frettloh, J., Huppe, M., Dlugaj, M., Matatko, N., Gaul, C., et al. (2010). Prevention of medication overuse in patients with migraine. Pain, 151(2), 404–413.
Article
PubMed
Google Scholar
Rossi, P., Di Lorenzo, C., Faroni, J., Cesarino, F., & Nappi, G. (2006). Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia, 26(9), 1097–1105.
Article
CAS
PubMed
Google Scholar
Rossi, P., Faroni, J. V., Tassorelli, C., & Nappi, G. (2013). Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): A prospective, randomized, open-label trial. The Journal of Headache and Pain, 14, 10. https://doi.org/10.1186/29-2377-14-10
Article
PubMed
PubMed Central
Google Scholar
Grande, R. B., Aaseth, K., Benth, J. S., Lundqvist, C., & Russell, M. B. (2011). Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. European Journal of Neurology, 18(1), 129–137.
Article
CAS
PubMed
Google Scholar
Kristoffersen, E. S., Straand, J., Russell, M. B., & Lundqvist, C. (2016). Disability, anxiety and depression in patients with medication-overuse headache in primary care—The BIMOH study. European Journal of Neurology, 23(Suppl 1), 28–35.
Article
PubMed
Google Scholar
Kristoffersen, E. S., Straand, J., Benth, J. S., Russell, M. B., & Lundqvist, C. (2017). Predictors of successful primary care detoxification treatment for medication-overuse headache. Acta Neurologica Scandinavica, 136(5), 486–494.
Article
CAS
PubMed
Google Scholar
Corbelli, I., Sarchielli, P., Eusebi, P., Cupini, L. M., Caproni, S., & Calabresi, P. (2018). Early management of patients with medication-overuse headache: Results from a multicentre clinical study. European Journal of Neurology, 25(8), 1027–1033.
Article
CAS
PubMed
Google Scholar
Krause, S. J., Stillman, M. J., Tepper, D. E., & Zajac, D. (2017). A prospective cohort study of outpatient interdisciplinary rehabilitation of chronic headache patients. Headache, 57(3), 428–440.
Article
PubMed
Google Scholar
Rothrock, J. F., Parada, V. A., Sims, C., Key, K., Walters, N. S., & Zweifler, R. M. (2006). The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache, 46(5), 726–731.
Article
PubMed
Google Scholar
Hering-Hanit, R., Cohen, A., & Horev, Z. (2001). Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. Journal of Child Neurology, 16, 448–449.
Article
CAS
PubMed
Google Scholar
Radat, F., & Lanteri-Minet, M. (2010). What is the role of dependence-related behavior in medication-overuse headache? Headache, 50(10), 1597–1611.
Article
PubMed
Google Scholar
Wallasch, T. M., & Kropp, P. (2012). Multidisciplinary integrated headache care: A prospective 12-month follow-up observational study. The Journal of Headache and Pain, 13(7), 521–529.
Article
PubMed
PubMed Central
Google Scholar
Carlsen, L. N., Westergaard, M. L., Bisgaard, M., Schytz, J. B., & Jensen, R. H. (2018). National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia, 38(7), 1316–1325.
Article
PubMed
Google Scholar
Kristoffersen, E. S., Straand, J., Russell, M. B., & Lundqvist, C. (2017). Lasting improvement of medication-overuse headache after brief intervention—A long-term follow-up in primary care. European Journal of Neurology, 24(7), 883–891.
Article
CAS
PubMed
Google Scholar
Diener, H. C., Bussone, G., Van Oene, J. C., Lahaye, M., Schwalen, S., & Goadsby, P. J. (2007). Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia, 27(7), 814–823.
Article
PubMed
Google Scholar
Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., et al. (2007). Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache, 47(2), 170–180.
Article
PubMed
Google Scholar
Silberstein, S., Lipton, R., Dodick, D., Freitag, F., Mathew, N., Brandes, J., et al. (2009). Topiramate treatment of chronic migraine: A randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache, 49(8), 1153–1162.
Article
PubMed
Google Scholar
Mei, D., Ferraro, D., Zelano, G., Capuano, A., Vollono, C., Gabriele, C., et al. (2006). Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clinical Neuropharmacology, 29(5), 269–275.
Article
CAS
PubMed
Google Scholar
Aurora, S. K., Dodick, D. W., Turkel, C. C., DeGryse, R. E., Silberstein, S. D., Lipton, R. B., et al. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia, 30(7), 793–803.
Article
CAS
PubMed
Google Scholar
Diener, H. C., Dodick, D. W., Aurora, S. K., Turkel, C. C., DeGryse, R. E., Lipton, R. B., et al. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia, 30(7), 804–814.
Article
CAS
PubMed
Google Scholar
Silberstein, S. D., Blumenfeld, A. M., Cady, R. K., Turner, I. M., Lipton, R. B., Diener, H. C., et al. (2013). OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. Journal of the Neurological Sciences, 331(1–2), 48–56.
Article
CAS
PubMed
Google Scholar
Tepper, S. J., Diener, H. C., Ashina, M., Brandes, J. L., Friedman, D. I., Reuter, U., et al. (2019). Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology, 92(20), e2309–e2320.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dodick, D. W., Doty, E. G., Aurora, S. K., Ruff, D. D., Stauffer, V. L., Jedynak, J., et al. (2021). Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia, 41(3), 340–352.
Article
PubMed
Google Scholar
Mulleners, W. M., Kim, B. K., Láinez, M. J. A., Lanteri-Minet, M., Pozo-Rosich, P., Wang, S., et al. (2020). Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): A multicentre, randomised, double-blind, placebo-controlled, phase 3b trial. Lancet Neurology, 19(10), 814–825.
Article
CAS
PubMed
Google Scholar
Silberstein, S. D., Cohen, J. M., Seminerio, M. J., Yang, R., Ashina, S., & Katsarava, Z. (2020). The impact of fremanezumab on medication overuse in patients with chronic migraine: Subgroup analysis of the HALO CM study. The Journal of Headache and Pain, 21(1), 114.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferrari, M. D., Diener, H. C., Ning, X., Galic, M., Cohen, J. M., Yang, R., et al. (2019). Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): A randomised, double-blind, placebo-controlled, phase 3b trial. Lancet, 394, 1030–1040.
Article
CAS
PubMed
Google Scholar
Ashina, M., Saper, J., Cady, R., Schaeffler, B. A., Biondi, D. M., Hirman, J., et al. (2020). Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia, 40(3), 241–254.
Article
PubMed
PubMed Central
Google Scholar
Lipton, R. B., Goadsby, P. J., Smith, J., Schaeffler, B. A., Biondi, D. M., Hirman, J., et al. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. Neurology, 94(13), e1365–e1377.
Article
CAS
PubMed
PubMed Central
Google Scholar
Diener, H. C., Marmura, M. J., Tepper, S. J., Cowan, R., Starling, A. J., Diamond, M. L., et al. (2021). Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2. Headache, 61(1), 125–136.
Article
PubMed
Google Scholar
Marmura, M. J., Diener, H.-C., Cowan, R. P., Tepper, S. J., Diamond, M. L., Starling, A. J., et al. (2021). Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14206):1421-31
Article
Google Scholar
Ray, J. C., Kapoor, M., Stark, R. J., Wang, S. J., Bendtsen, L., Matharu, M., et al. (2021). Calcitonin gene related peptide in migraine: Current therapeutics, future implications and potential off-target effects. Journal of Neurology, Neurosurgery and Psychiatry, 92(12), 1325–1334.
Article
PubMed
Google Scholar
Edvinsson, L. (2002). Calcitonin gene-related peptide (CGRP) in cerebrovascular disease. The Scientific World Journal, 2, 1484–1490.
Article
PubMed
PubMed Central
Google Scholar
Peskar, B. M., Wong, H. C., Walsh, J. H., & Holzer, P. (1993). A monoclonal antibody to calcitonin gene-related peptide abolishes capsaicin-induced gastroprotection. European Journal of Pharmacology, 250(1), 201–203.
Article
CAS
PubMed
Google Scholar
Smillie, S. J., King, R., Kodji, X., Outzen, E., Pozsgai, G., Fernandes, E., et al. (2014). An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension, 63(5), 1056–1062.
Article
CAS
PubMed
Google Scholar
Breen, I. D., Mangold, A. R., & VanderPluym, J. H. (2021). The evolving understanding of risk with calcitonin gene-related peptide monoclonal antibodies based on real-world data: A focus on hypertension and Raynaud phenomenon. Headache: The Journal of Head and Face Pain, 61(8), 1274–1276.
Article
Google Scholar
Evans, R. W. (2019). Raynaud’s phenomenon associated with calcitonin gene-related peptide monoclonal antibody antagonists. Headache, 59(8), 1360–1364.
Article
PubMed
Google Scholar
Manickam, A. H., Buture, A., Tomkins, E., & Ruttledge, M. (2021). Raynaud’s phenomenon secondary to erenumab in a patient with chronic migraine. Clin Case Rep., 9(8), e04625.
Article
PubMed
PubMed Central
Google Scholar
Khalil, Z., & Helme, R. (1996). Sensory peptides as neuromodulators of wound healing in aged rats. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 51(5), B354–B361.
Article
CAS
Google Scholar
Yin, Q., Sun, L., Cai, X., Lou, F., Sun, Y., Wang, B., et al. (2022). Lidocaine ameliorates psoriasis by obstructing pathogenic CGRP signaling-mediated sensory neuron-dendritic cell communication. Journal of Investigative Dermatology.
Sarchielli, P., Messina, P., Cupini, L. M., Tedeschi, G., Di Piero, V., Livrea, P., et al. (2014). Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial. European Neuropsychopharmacology, 24(8), 1289–1297.
Article
CAS
PubMed
Google Scholar
Pini, L. A., Guerzoni, S., Cainazzo, M. M., Ferrari, A., Sarchielli, P., Tiraferri, I., et al. (2012). Nabilone for the treatment of medication overuse headache: Results of a preliminary double-blind, active-controlled, randomized trial. The Journal of Headache and Pain, 13(8), 677–684.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rizzato, B., Leone, G., Misaggi, G., Zivi, I., & Diomedi, M. (2011). Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: An open-label prospective study. Clinical Neuropharmacology, 34(2), 74–78.
Article
CAS
PubMed
Google Scholar
Rudra, R. T., Gordin, V., & Xu, L. (2020). Acupuncture in the management of medication overuse and drug-induced aseptic meningitis headache: A case report. Journal of Acupuncture and Meridian Studies, 13(2), 58–60.
Article
PubMed
Google Scholar
Roceanu, A., Antochi, F., & Bajenaru, O. (2014). Chronic migraine—New treatment options. Maedica (Bucur)., 9(4), 401–404.
PubMed
PubMed Central
Google Scholar
Kropp, P., Meyer, B., Dresler, T., Fritsche, G., Gaul, C., Niederberger, U., et al. (2017). Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft. Schmerz, 31(5), 433–447.
Article
CAS
PubMed
Google Scholar
Rausa, M., Palomba, D., Cevoli, S., Lazzerini, L., Sancisi, E., Cortelli, P., et al. (2016). Biofeedback in the prophylactic treatment of medication overuse headache: A pilot randomized controlled trial. The Journal of Headache and Pain, 17(1), 87.
Article
PubMed
PubMed Central
CAS
Google Scholar
Grazzi, L., Sansone, E., Raggi, A., D’Amico, D., De Giorgio, A., Leonardi, M., et al. (2017). Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: An effectiveness trial with a one-year follow-up. The Journal of Headache and Pain, 18(1), 15.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bottiroli, S., Viana, M., Sances, G., Ghiotto, N., Guaschino, E., Galli, F., et al. (2016). Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse. Cephalalgia, 36(14), 1356–1365.
Article
CAS
PubMed
Google Scholar
Westergaard, M. L., Glumer, C., Hansen, E. H., & Jensen, R. H. (2016). Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey. Cephalalgia, 36(1), 15–28.
Article
PubMed
Google Scholar
Zeeberg, P., Olesen, J., & Jensen, R. (2006). Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia, 26(10), 1192–1198.
Article
CAS
PubMed
Google Scholar
Kristoffersen, E. S., Straand, J., Vetvik, K. G., Benth, J. S., Russell, M. B., & Lundqvist, C. (2015). Brief intervention for medication-overuse headache in primary care. The BIMOH study: A double-blind pragmatic cluster randomised parallel controlled trial. Journal of Neurology, Neurosurgery & Psychiatry, 86(5), 505–512.
Article
Google Scholar
Creac’h, C., Frappe, P., Cancade, M., Laurent, B., Peyron, R., Demarquay, G., et al. (2011). In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial. Cephalalgia, 31(11), 1189–1198.
Article
CAS
PubMed
Google Scholar
Tassorelli, C., Jensen, R., Allena, M., De Icco, R., Sances, G., Katsarava, Z., et al. (2014). A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia, 34(9), 645–655.
Article
PubMed
Google Scholar
Chiang, C. C., Schwedt, T. J., Wang, S. J., & Dodick, D. W. (2016). Treatment of medication-overuse headache: A systematic review. Cephalalgia, 36(4), 371–386.
Article
PubMed
Google Scholar
Hagen, K., Albretsen, C., Vilming, S. T., Salvesen, R., Gronning, M., Helde, G., et al. (2009). Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia, 29(2), 221–232.
Article
CAS
PubMed
Google Scholar
Munksgaard, S. B., Bendtsen, L., & Jensen, R. H. (2012). Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design. Cephalalgia, 32(11), 834–844.
Article
PubMed
Google Scholar
Carlsen, L. N., Munksgaard, S. B., Nielsen, M., Engelstoft, I. M. S., Westergaard, M. L., Bendtsen, L., et al. (2020). Comparison of 3 treatment strategies for medication overuse headache: A randomized clinical trial. JAMA Neurology, 77(9), 1069–1078.
Article
PubMed
Google Scholar
Engelstoft, I. M. S., Carlsen, L. N., Munksgaard, S. B., Nielsen, M., Jensen, R. H., & Bendtsen, L. (2019). Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial. European Journal of Pain, 23(6), 1162–1170.
Article
PubMed
Google Scholar
Freitag, F. G., Lake, A., 3rd., Lipton, R., Cady, R., Diamond, S., Silberstein, S., et al. (2004). Inpatient treatment of headache: An evidence-based assessment. Headache, 44(4), 342–360.
Article
PubMed
Google Scholar
Diener, H. C., Antonaci, F., Braschinsky, M., Evers, S., Jensen, R., Lainez, M., et al. (2020). European Academy of Neurology guideline on the management of medication-overuse headache. European Journal of Neurology, 27(7), 1102–1116.
Article
CAS
PubMed
Google Scholar
Katsarava, Z., Fritsche, G., Muessig, M., Diener, H. C., & Limmroth, V. (2001). Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology, 57, 1694–1698.
Article
CAS
PubMed
Google Scholar
Boe, M. G., Mygland, A., & Salvesen, R. (2007). Prednisolone does not reduce withdrawal headache: A randomized, double-blind study. Neurology, 69(1), 26–31.
Article
PubMed
CAS
Google Scholar
Rabe, K., Pageler, L., Gaul, C., Lampl, C., Kraya, T., Foerderreuther, S., et al. (2013). Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind, placebo-controlled study. Cephalalgia, 33(3), 202–207.
Article
PubMed
Google Scholar
Cevoli, S., Giannini, G., Favoni, V., Terlizzi, R., Sancisi, E., Nicodemo, M., et al. (2017). Treatment of withdrawal headache in patients with medication overuse headache: A pilot study. The Journal of Headache and Pain, 18(1), 56.
Article
PubMed
PubMed Central
CAS
Google Scholar
Taghdiri, F., Togha, M., Razeghi Jahromi, S., & Paknejad, S. M. (2015). Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind clinical trial. Headache, 55(1), 128–135.
Article
PubMed
Google Scholar
Krymchantowski, A. V., & Barbosa, J. S. (2000). Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia, 20, 107–113.
Article
CAS
PubMed
Google Scholar
Paolucci, M., Altamura, C., Brunelli, N., Rizzo, A. C., Assenza, F., Pasqualetti, P., et al. (2017). Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache. Neurological Sciences, 38(11), 2025–2029.
Article
PubMed
Google Scholar
Raggi, A., Giovannetti, A. M., Leonardi, M., Sansone, E., Schiavolin, S., Curone, M., et al. (2017). Predictors of 12-months relapse after withdrawal treatment in hospitalized patients with chronic migraine associated with medication overuse: A longitudinal observational study. Headache, 57(1), 60–70.
Article
PubMed
Google Scholar
Bottiroli, S., Allena, M., Sances, G., De Icco, R., Avenali, M., Fadic, R., et al. (2019). Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project. Cephalalgia, 39(1), 135–147.
Article
PubMed
Google Scholar
Liu, H., Zhang, M., Chen, X., Sun, S., Dong, Z., & Yu, S. (2019). Rates and predictors of relapse in medication overuse headache: A clinic-based study from China. European Neurology, 82(4–6), 68–74.
Article
PubMed
Google Scholar
Carlsen, L. N., Munksgaard, S. B., Jensen, R. H., & Bendtsen, L. (2018). Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia, 38(2), 225–236.
Article
PubMed
Google Scholar
Zidverc-Trajkovic, J. J., Pekmezovic, T., Jovanovic, Z., Pavlovic, A., Mijajlovic, M., Radojicic, A., et al. (2018). Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study. Cephalalgia, 38(2), 265–273.
Article
PubMed
Google Scholar
Gaul, C., van Doorn, C., Webering, N., Dlugaj, M., Katsarava, Z., Diener, H., et al. (2011). Efficacy of a headache specific multidisciplinary treatment program and adherence to treatment in a tertiary headache center. The Journal of Headache and Pain, 12, 348.
Google Scholar